Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Beam Therapeutics
325 Vassar Street
Cambridge, MA 02139
https://beamtx.com/

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Headquartered in Cambridge, Massachusetts, the company is backed by F-Prime Capital Partners and ARCH Venture Partners, two of the world's leading biotech venture capital firms.

Key Contact
NameTitleE-Mail
John EvansCEO


Funding Events
DateAmountTypeInvestors
05/14/18$87,000,000Series A ARCH Venture Partners
F-Prime Capital Partners  
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.